Module 1: Medication: The Missing Variable in Return to Work

Why this reading matters

The video introduced the idea that medication is the missing variable in return to work. This reading takes that idea apart and puts it back together in a way you can use on a real caseload or a real site. By the end, you should be able to look at any RTW plan or fitness for work decision and ask: where is medication in this, who is responsible for noticing it, and what would change if we took it seriously?

What a typical RTW plan actually contains

Pull out any RTW plan you have written or approved in the last year. It will almost certainly contain:

• hours, usually graded upward over several weeks
• suitable duties and physical restrictions (lifting limits, no overhead work, sit and stand as needed)
• treatment, often listed as physiotherapy, exercise physiology or psychology appointments
• a review date and the names of the people involved

What it will almost never contain is any reference to the medicines the worker is taking, how those medicines are changing, or how they interact with the duties in the plan. That gap is not a small administrative oversight. It means the plan is built on an incomplete picture of the worker's capacity.

Think about what the plan is trying to do. It is trying to match what the worker can safely do with what the workplace can offer, and to increase both over time. Medication affects both sides of that equation. It affects what the worker can safely do today, through impairment. It also affects how quickly the worker can progress, through fatigue, weight change, mood and pain sensitivity. A plan that ignores medication is guessing at capacity.

The two risks, in more depth

The video separated medication risk into two types. It is worth spending more time on each, because they lead to different actions and different escalation paths later in the course.

Impairment is a safety risk

Impairment is the risk most people think of first. It matters most where the work is safety-critical: driving, mobile plant, heights, confined spaces, hazardous chemicals, lone remote work and decision-critical roles. For these tasks, a small reduction in reaction time or alertness can be the difference between a near miss and a serious incident.

Impairment is also the risk most directly connected to WHS duties. If the workplace knows, or reasonably should know, that a worker may be impaired, it needs to manage that risk like any other hazard.

Stalled recovery is a capacity risk

Stalled recovery is quieter. Nobody gets hurt on the day. Instead, the worker's progress slows. They stay at four hours a day for six weeks. They report being exhausted by mid-morning. They gain weight, which makes physical duties harder. Their mood drops. Their pain seems to get worse even as their medicines increase.

The trap with stalled recovery is that everyone tends to explain it with the injury. "The back is just taking longer." "It's a psychological overlay." Sometimes that is true. But sometimes the medicines are part of the picture, and nobody looks, because nobody has been trained to look.

Why both risks need managing together

The two risks can pull in opposite directions. A plan that focuses only on impairment might keep a worker off every safety-critical task for months, which protects safety but slows recovery and can damage the worker's confidence and connection to the job. A plan that focuses only on recovery might push hours and duties up without noticing that a new medicine has just been added. Good practice keeps both questions on the table at every review: is this worker safe, and is this worker progressing?

The legal frame in practical terms

This section is general information to help you think about your role. It is not legal advice, and your organisation's own policies and legal advisors take priority.

The PCBU's duty

Under the model WHS laws adopted across most of Australia, a PCBU must ensure, so far as is reasonably practicable, the health and safety of workers and others affected by the work. In practice, managing medication-related impairment follows the same logic as managing any other hazard:

1. Identify that impairment from medication is a foreseeable hazard, especially in safety-critical roles.
2. Assess the risk for the individual and the specific task, which is what the Medication-Task Matrix in Module 4 does.
3. Control the risk using sensible measures: adjusted duties, adjusted start times, supervision, no lone work, temporary removal from a task.
4. Review the controls, especially when anything changes.

The words "so far as is reasonably practicable" matter. They do not require a workplace to eliminate every conceivable risk. They require a workplace to do what is reasonable, given how likely the harm is, how serious it would be, what is known about the hazard and the ways of controlling it, and what those controls involve.

The worker's duty

Workers must take reasonable care for their own health and safety and must not adversely affect the health and safety of others. They must also comply, so far as they reasonably can, with reasonable instructions and policies. This is why fitness for work policies ask workers to declare medicines that may affect their ability to work safely. A worker who knows a new sleeping tablet leaves them groggy and still climbs into a loader at 5 am without saying anything is not meeting that duty.

But the duty only works if the system makes it safe to speak up. If a worker believes that declaring a medicine will cost them their job, the duty becomes a reason to stay silent. You will see this theme again in Module 5.

Industry-specific requirements

Some industries have additional requirements. Queensland coal mines, for example, must have systems within their safety and health management system for workers to declare medication that could impair them. Other high-risk industries may have their own requirements. Check what applies to your sector and state.

Anti-discrimination and privacy

Running alongside WHS duties are anti-discrimination and privacy laws. In general terms:

• Decisions about a worker's duties must be based on a genuine assessment of that individual and the inherent requirements of the role, not on assumptions about a medicine or a condition.
• Consider whether adjustments would allow the person to work safely before deciding they cannot do a task.
• Medication information is health information. It must be collected only where needed, stored securely, and shared only with people who need it, usually with the worker's consent.

This is why blanket rules are a problem. A rule such as "nobody on opioids can work on site" treats every worker on every opioid at every dose the same, regardless of the task, the dose, how long they have been stable, or what they can actually do. It is likely to be unlawful, it is not good safety practice, and it pushes workers to hide their medicines.

The right question is always individual: what can this person safely do, on these medicines, at this time?

Roles: who does what, and what they do not do

Confusion about roles is one of the most common reasons medication issues are either ignored or handled badly. The table below expands on the four roles from the video.

Two further roles often appear:

• Occupational physician or medical review officer. Provides independent medical advice on fitness for specific tasks, and reviews positive drug test results against declared medicines.
• Clinical pharmacist. Reviews the whole medication picture, identifies impairment, interaction and recovery risks, and advises the treating doctor. The treating doctor remains the decision-maker.

The key principle: only the prescriber makes clinical decisions about medication. Everyone else has a part in noticing, asking and escalating. That division protects the worker, protects you, and keeps the treating relationship intact.

Timing: thinking in timelines, not snapshots

The video introduced four high-risk moments: starting a medicine, increasing a dose, adding a medicine and stopping a medicine. The practical skill here is learning to think in timelines.

When a worker's medication comes up, the most useful question is often not "what are they on?" but "what has changed, and when?" Consider two workers on the same medicine at the same dose:

• Worker A has taken it at a stable dose for three months, reports no drowsiness, and nothing has been observed at work.
• Worker B started it four days ago and is due to return to their normal roster on Monday.

On paper they look the same. In reality, Worker B is in the window where sedation and dizziness are usually at their worst, while Worker A has had time for some tolerance to develop. The risk is different, so the response should be different.

The same thinking applies to stopping. A worker who decides to stop a sleeping tablet or an opioid abruptly so they can "pass" a return to work assessment may be entering withdrawal, with poor sleep, anxiety, sweating and pain flares. Sudden stops can be as risky as starts. This is one reason no one other than the prescriber should ever suggest stopping a medicine.

A worked example: open-cut mine, maintenance crew

The following example is invented and de-identified.

Dale is a 44-year-old heavy diesel fitter at an open-cut coal mine. He injured his knee climbing down from a dragline platform and has had arthroscopic surgery. He is now at week 6 of his RTW plan, working 6 hours a day on restricted duties in the workshop. The plan lists physiotherapy twice a week, no climbing, no kneeling and a review in 2 weeks. It does not mention medication.

At the review, the rehab provider asks a general question: "Has anything changed with your treatment or medicines since we last met?" Dale mentions that his GP has added a nerve pain tablet because of burning pain down his shin, and that he feels "a bit wobbly" when he stands up. He also mentions he is still taking a painkiller at night that "helps him sleep".

Without naming or judging any medicine, a few things are already clear:

• Something impairing has been started recently. That is a high-risk moment.
• There may now be two impairing medicines, which stack.
• Dale is reporting an effect, unsteadiness, that matters for the duties he is about to be upgraded to.
• The plan's next step was to return him to light vehicle driving around the pit and some platform work with a harness.

A plan that ignored medication would have upgraded his duties at the next review. A medication-aware plan pauses the upgrade to Tier 3 tasks, keeps him in the workshop, and, with his consent, asks his GP function-focused questions about alertness, coordination and dose timing. The rehab provider also notes that if the unsteadiness continues and hours stop progressing, it may be worth suggesting a clinical pharmacist review to the insurer.

Notice what no one did. No one asked for his diagnosis. No one told him to stop anything. No one sent him home. The focus stayed on function and safety, and Dale stayed at work.

Common mistakes

Treating medication as "none of our business". Respecting clinical boundaries does not mean ignoring medication. You can and should ask function-focused questions.

Asking the wrong questions. "What are you on?" and "What's it for?" are intrusive and often unnecessary. "Have you started or changed any medicines that might affect your alertness or balance?" gets to the safety issue.

Relying on the worker's self-assessment alone. Sedation often impairs a person's ability to judge their own impairment. "I feel fine" is useful information, but it does not close the question for a safety-critical task.

Blanket bans. A rule against a class of medicine, regardless of task, dose or stability, is likely to be unlawful and drives non-disclosure.

Assuming the injury explains everything. When progress stalls, check whether anything changed with medication around the time it stopped.

Stepping into clinical territory. Suggesting a worker reduce or stop a medicine, or recommending a different one, is outside your role and can cause harm through withdrawal.

Forgetting over-the-counter medicines. Sedating antihistamines bought for sleep or allergies can matter as much as prescribed medicines.

Key points

• Medication creates two separate risks in RTW: impairment (safety) and stalled recovery (capacity). Manage both.
• Most RTW plans contain no medication information, which means capacity is being estimated with an incomplete picture.
• PCBUs must manage impairment risk so far as is reasonably practicable. Workers must take reasonable care, including declaring medicines that may affect safety.
• Decisions must be individual, based on genuine safety and inherent requirements. Blanket bans are likely to be unlawful.
• Only the prescriber makes clinical decisions about medication. Everyone else notices, asks and escalates.
• Risk peaks when a medicine is started, increased, added or stopped. Think in timelines.
• The two questions for every review: is this worker safe, and is this worker progressing?